Privia Health Group, Inc. (PRVA) P/E Ratio History
Fairly ValuedTrading at 131.5x, near 5Y avg of 153.4x · 38th percentile · In line with own history · Data 2023–2026
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Privia Health Group, Inc. (PRVA) trades at a price-to-earnings ratio of 131.5x, with a stock price of $23.67 and trailing twelve-month earnings per share of $0.17.
The current P/E is 14% below its 5-year average of 153.4x. Over the past five years, PRVA's P/E has ranged from a low of 74.2x to a high of 255.4x, placing the current valuation at the 38th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, PRVA trades at a 494% premium to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, PRVA commands a significant premium over the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PRVA DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PRVA Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
PRVA P/E vs Peers
Care Delivery Networks and Value-Based Care peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $4B | 20.9Lowest | 0.40Best | -12% | |
| $145B | 148.7 | - | -11% | |
| $364B | 30.3 | - | -15% | |
| $125B | 70.7 | - | -62% | |
| $43B | 36.7 | - | -1% | |
| $25B | 28.2 | 1.55 | +26%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
PRVA Historical P/E Data (2023–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $20.57 | $0.17 | 122.6x | -20% |
| FY2025 Q4 | Dec 31 2025 | $23.71 | $0.17 | 136.0x | -11% |
| FY2025 Q3 | - | $24.90 | $0.14 | 179.1x | +17% |
| FY2025 Q2 | Jun 30 2025 | $23.00 | $0.12 | 198.8x | +30% |
| FY2025 Q1 | Mar 31 2025 | $22.45 | $0.12 | 179.9x | +17% |
| FY2024 Q4 | - | $19.55 | $0.11 | 170.3x | +11% |
| FY2024 Q3 | Sep 30 2024 | $18.21 | $0.10 | 182.1x | +19% |
| FY2024 Q2 | Jun 30 2024 | $17.38 | $0.12 | 144.8x | -6% |
| FY2024 Q1 | Mar 31 2024 | $19.59 | $0.15 | 130.6x | -15% |
| FY2023 Q4 | Dec 31 2023 | $23.03 | $0.19 | 121.2x | -21% |
| FY2023 Q3 | Sep 30 2023 | $23.00 | $0.31 | 74.2x | -52% |
| FY2023 Q2 | Jun 30 2023 | $26.11 | $0.26 | 98.7x | -36% |
| FY2023 Q1 | Mar 31 2023 | $27.61 | $0.11 | 255.4x | +67% |
Average P/E for displayed period: 153.4x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PRVA — Frequently Asked Questions
Quick answers to the most common questions about buying PRVA stock.
What is PRVA's P/E ratio?
Privia Health Group, Inc. (PRVA) trailing twelve-month P/E ratio is 131.5x, based on TTM diluted EPS of $0.17. The 5-year average P/E is 153.4x and the historical range spans 74.2x to 255.4x.
Is PRVA stock overvalued or undervalued?
PRVA trades at 131.5x P/E, near its 5-year average of 153.4x. The 38th percentile ranking within the 74.2x–255.4x historical range places valuation within normal bounds.
Is PRVA stock expensive?
PRVA is fairly valued relative to its own history. The current P/E of 131.5x is near the 5-year average of 153.4x (38th percentile of historical range).
What is PRVA's historical P/E range?
Over the past 5 years, PRVA's P/E ratio has ranged from 74.2x to 255.4x, with a median of 144.8x and an average of 153.4x. The current P/E of 131.5x places the stock at the 38th percentile of this range. Full historical data spans 2023–2026.
How does PRVA's P/E compare to the S&P 500?
PRVA trades at 131.5x P/E versus the S&P 500 median of 24.4x. The 439% premium to the market typically reflects higher expected earnings growth or quality.
How does PRVA's valuation compare to Healthcare peers?
Privia Health Group, Inc. P/E of 131.5x compares to the Healthcare sector median of 22.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is PRVA's PEG ratio?
PRVA PEG ratio is N/A, based on a P/E of 131.5x and EPS growth of 63.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is PRVA's earnings yield?
PRVA earnings yield is 0.76%, the inverse of its 131.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.